CD36 and breast cancer: Furthermore, CD36 in interaction with FABP4 that enhance the import of free fatty acids from adipocytes in the tumor microenvironment leads to activation of STAT3 signaling, metabolic reprogramming with a shift toward beta oxidation and promoting breast cancer progression [43].